Peter G. Linde
2020
In 2020, Peter G. Linde earned a total compensation of $2.8M as Chief Medical Officer at Morphic Holding.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Non-Equity Incentive Plan | $151,967 |
| Option Awards | $1,345,397 |
| Salary | $344,375 |
| Stock Awards | $717,775 |
| Other | $8,550 |
| Total | $2,793,064 |
Linde received $1.3M in option awards, accounting for 48% of the total pay in 2020.
Linde also received $225K in bonus, $152K in non-equity incentive plan, $344.4K in salary, $717.8K in stock awards and $8.6K in other compensation.
Rankings
In 2020, Peter G. Linde's compensation ranked 4,133rd out of 13,090 executives tracked by ExecPay. In other words, Linde earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,133 out of 13,090 | 68th |
Division Manufacturing | 1,667 out of 5,621 | 70th |
Major group Chemicals And Allied Products | 638 out of 2,254 | 72nd |
Industry group Drugs | 547 out of 1,954 | 72nd |
Industry Pharmaceutical Preparations | 416 out of 1,459 | 72nd |
Source: SEC filing on April 29, 2021.
Linde's colleagues
We found four more compensation records of executives who worked with Peter G. Linde at Morphic Holding in 2020.